What is atypical ductal hyper plasia?

Answer 1

condition that affects cells in the breast. Atypical hyperplasia describes an accumulation of abnormal cells in a breast duct (atypical ductal hyperplasia) or lobule (atypical lobular hyperplasia).

Atypical hyperplasia isn't cancer, but it can be a forerunner to the development of Breast cancer. Over the course of your lifetime, if the atypical hyperplasia cells keep dividing and become more abnormal, your condition may be reclassified as noninvasive breast cancer (carcinoma in situ) or breast cancer.

If you've been diagnosed with atypical hyperplasia, you have an increased risk of developing breast cancer in the future. For this reason, doctors sometimes recommend more frequent breast cancer screening and careful consideration of medications and other strategies to reduce breast cancer risk.Symptoms

• Mayo Clinic products and services
• Breast cancer treatment at Mayo Clinic
• Mayo Clinic Cancer Center

• See AlsoHand Scheduled

  Section Focus

  Related Links

• Breast cancer

  Related Guides

  Children

  Parent

References

1. Lester SC. The breast. In: Kumar V, et al. Robbins and Cotran Pathologic Basis of Disease. 8th ed. Philadelphia, Pa.: Saunders Elsevier; 2010. http://www.mdconsult.com/books/about.do?about=true&eid=4-u1.0-B978-1-4377-0792-2..X5001-9&isbn=978-1-4377-0792-2&uniqId=273803839-4. Accessed Aug. 17, 2011.
2. Bombonati A, et al. The molecular pathology of breast cancer progression. Journal of Pathology. 2011;223:307.
3. Hartmann LC, et al. Benign breast disease and the risk of breast cancer. The New England Journal of Medicine. 2005;353:229.
4. London SJ, et al. A prospective study of benign breast disease and the risk of breast cancer. Journal of the American Medical Association. 1992;267:941.
5. Degnim AC, et al. Stratification of breast cancer risk in women with atypia: A Mayo cohort study. Journal of Clinical Oncology. 2007;25:2671.
6. Dupont WD, et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer. 1993;71:1258.
7. Breast cancer risk reduction. Fort Washington, Pa.: National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed Aug. 17, 2011.
8. Breast cancer screening and diagnosis. Fort Washington, Pa.: National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed Aug. 17, 2011.
9. Pruthi S (expert opinion). Mayo Clinic, Rochester, Minn. Aug. 31, 2011.
10. Goss PE, et al. Exemestane for breast-cancer prevention in postmenopausal women. The New England Journal of Medicine. 2011;25:2381.

DS01018 Oct. 1, 2011

© 1998-2012 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

• Reprints
• Print

• Share on:

• Twitter
• Facebook
• email

close window E-mail this page* Required fields* Recipient's e-mail address* Your name* Your e-mail

Clicking "send" signifies that you have read and agree to our privacy policy.

Share this on ...

• StumbleUpon
• Digg
• del.icio.us
• Facebook
• MySpace

Link to this pageTo link to this page, copy this HTML and paste it onto your Web page.

Atypical hyperplasia of the breastGuidelines for sites linking to MayoClinic.com